Pemigatinib for adults with previously treated, locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions/rearrangements

Daniel Walden, Cody Eslinger, Tanios Bekaii-Saab

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'Pemigatinib for adults with previously treated, locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions/rearrangements'. Together they form a unique fingerprint.

Medicine & Life Sciences